October 28, 2016 12:01 PM ET

Healthcare Providers and Services

Company Overview of Beth Israel Deaconess Medical Center, Inc.

Company Overview

Beth Israel Deaconess Medical Center, Inc. operates a hospital in Massachusetts. It offers cancer, chest and digestive disease, and spine center services, as well as transplant institute and nursing services. The company also provides Biomedical Research, such as vascular and transplantation research, signal transduction in cancer, and molecular imaging services. In addition, it offers nursing, social work, and health sciences training to medical students, interns, residents, and professionals, as well as graduate and undergraduate medical education services. The company was founded as The Beth Israel Hospital Association in 1915 and changed its name to Beth Israel Deaconess Medical Center, ...

330 Brookline Avenue

Boston, MA 02215

United States

Founded in 1915





Key Executives for Beth Israel Deaconess Medical Center, Inc.

President and Chief Executive Officer
Age: 51
Chief of Department of Medicine
Chairman of Obstetrics & Gynecology Departments
Chief of Clinical Research and Cardiovascular Division and Associate Professor of Medicine
Vice President of Research Operations
Compensation as of Fiscal Year 2016.

Beth Israel Deaconess Medical Center, Inc. Key Developments

Beth Israel Deaconess Medical Center, Inc. Appoints Peter Healy as President

Beth Israel Deaconess Medical Center announced that it would create several new executive positions around the Longwood hospital, creating two new positions - a president and chief financial officer - to oversee the system. Peter Healy, currently the CEO of Beth Israel's Milton hospital, has been appointed president. Meanwhile, Beth Israel's CEO, Dr. Kevin Tabb, will shift his focus to organizational growth, which includes yet-to-be-released details on a fundraising campaign to support research efforts and institutional improvements.

Leon V. & Marilyn L. Rosenberg Clinical Cancer Center Appoints Manuel Hidalgo as Clinical Director and Chief of the Hospital’s Division of Hematology-Oncology

PharmaCyte Biotech, Inc. announced that Manuel Hidalgo, MD, PhD, an internationally respected oncologist and a member of PharmaCyte ’s Scientific Advisory Board, has been named Clinical Director of the Leon V. & Marilyn L. Rosenberg Clinical Cancer Center, part of the Cancer Center at the Beth Israel Deaconess Medical Center (BIDMC) in Boston. Dr. Hidalgo has also been appointed Chief of the hospital’s Division of Hematology-Oncology. In his role at the prestigious medical center, Dr. Hidalgo will oversee all of BIDMC’s clinical cancer programs. Dr. Hidalgo, whose groundbreaking work in experimental cancer therapy and tumor model development has led to key advances in the treatment of pancreatic cancer, will join the BIDMC this month. He is currently serving as the Director of the Clinical Research Program and Vice Director of Translational Research at the Spanish National Cancer Center. Dr. Hidalgo also holds faculty positions at University CEU San Pablo and Johns Hopkins University.

Beth Israel Deaconess Medical Center Announces New Center for Outcomes Research in Cardiology; Appoints Robert W. Yeh as Director of the Smith Center

Beth Israel Deaconess Medical Center announced the launch of a new research center that will use rigorous scientific methods to evaluate and transform the delivery of care for cardiovascular conditions in the United States. The Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center (BIDMC) will bring together clinicians and researchers to examine the most pressing challenges in cardiovascular care, including clinical effectiveness, cost, quality, ethics and public policy. Robert W. Yeh, MD, MSc, MBA, has been named Director of the Smith Center. A national leader in cardiovascular outcomes research and an interventional cardiologist specializing in complex coronary interventions, Yeh joins BIDMC from Massachusetts General Hospital (MGH). Yeh has led seminal research using electronic health record data to inform cardiovascular epidemiology and improve clinical risk prediction to maximize procedural value. He is an expert in the use of observational research methods in examining comparative effectiveness and evaluating health policy. In addition to his leadership of the Smith Center, he will maintain a clinical cardiology practice at the CardioVascular Institute at BIDMC and will continue to serve as Medical Director of Trial Design at the Harvard Clinical Research Institute.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Beth Israel Deaconess Medical Center, Inc., please visit www.bidmc.org. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.